BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32040481)

  • 1. The association between microRNA-21 and hypertension-induced cardiac remodeling.
    Watanabe K; Narumi T; Watanabe T; Otaki Y; Takahashi T; Aono T; Goto J; Toshima T; Sugai T; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Watanabe M
    PLoS One; 2020; 15(2):e0226053. PubMed ID: 32040481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.
    Khan SA; Dong H; Joyce J; Sasaki T; Chu ML; Tsuda T
    Lab Invest; 2016 Jul; 96(7):773-83. PubMed ID: 27111286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3.
    Zhang J; Lang Y; Guo L; Pei Y; Hao S; Liang Z; Su G; Shu L; Liu H; Huang C; Xu J
    Cell Physiol Biochem; 2018; 50(6):2176-2187. PubMed ID: 30415251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.
    Zhao L; Mi Y; Guan H; Xu Y; Mei Y
    Eur J Pharmacol; 2016 Jul; 783():33-46. PubMed ID: 27108788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feedback loop between miR-21, PDCD4 and AP-1 functions as a driving force for renal fibrogenesis.
    Sun Q; Miao J; Luo J; Yuan Q; Cao H; Su W; Zhou Y; Jiang L; Fang L; Dai C; Zen K; Yang J
    J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29361523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
    Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockage of AKAP12 accelerates angiotensin II (Ang II)-induced cardiac injury in mice by regulating the transforming growth factor β1 (TGF-β1) pathway.
    Li Y; Yu QH; Chu Y; Wu WM; Song JX; Zhu XB; Wang Q
    Biochem Biophys Res Commun; 2018 May; 499(2):128-135. PubMed ID: 29501491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
    Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets.
    Zhan H; Huang F; Niu Q; Jiao M; Han X; Zhang K; Ma W; Mi S; Guo S; Zhao Z
    Oxid Med Cell Longev; 2021; 2021():8889195. PubMed ID: 34646427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
    Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
    Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.
    Lyu H; Li X; Wu Q; Hao L
    J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.
    Zhang Z; Zha Y; Hu W; Huang Z; Gao Z; Zang Y; Chen J; Dong L; Zhang J
    J Biol Chem; 2013 Dec; 288(52):37082-93. PubMed ID: 24196965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miR-24, Furin, and Transforming Growth Factor-β1 Signal Pathway in Fibrosis After Cardiac Infarction.
    Chen Z; Lu S; Xu M; Liu P; Ren R; Ma W
    Med Sci Monit; 2017 Jan; 23():65-70. PubMed ID: 28055991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
    Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
    J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
    Li AL; Lv JB; Gao L
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
    Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
    Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.